Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

ADAM22 Mouse anti-Human, Mouse, Rat, Clone: S46-30, Invitrogen™

Mouse Monoclonal Antibody

Manufacturer:  Invitrogen MA527622

Catalog No. PIMA527622


Add to cart

Description

Description

This gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. This gene is highly expressed in the brain and may function as an integrin ligand in the brain. Alternative splicing results in several transcript variants.
Specifications

Specifications

ADAM22
Monoclonal
1 mg/ml
PBS with 50% glycerol and 0.09% sodium azide; pH 7.4
Q9P0K1, Q9R1V6
MDC2, Disintegrin and metalloproteinase domain-containing protein 22, Metalloproteinase disintegrin ADAM22-3, Metalloproteinase-like disintegrin-like and cysteine-rich protein 2, ADAM 22, ADAM metallopeptidase domain 22, MGC149832
Mouse
IgG2B
100 μg
-20°C
Primary
11496, 53616, 57033
Immunocytochemistry, Immunofluorescence, Immunohistochemistry (PFA fixed), Immunoprecipitation, Western Blot
S46-30
Unconjugated
ADAM22
Liquid
ADAM22
Fusion protein amino acids 757-857 (cytoplasmic region) of mouse ADAM22
Protein G
RUO
Antibody
Monoclonal
Human, Mouse, Rat
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit